Vicplas International Ltd (569.SI stock) heads into a pre-market earnings spotlight with results due 12 Mar 2026. The shares trade at S$0.09 on the SES in Singapore and volume is light at 15,400 shares. Investors will watch cash flow metrics and order trends in the medical devices and piping divisions for signs of margin recovery and revenue stability.

Earnings calendar and catalyst: 569.SI stock earnings set for 12 Mar 2026

Vicplas will report results on 12 Mar 2026. This is the immediate catalyst for the stock’s near-term move. The market expects clarity on sterile device assembly volumes and contract pipeline in Malaysia and China.

Management commentary on working capital and cash conversion will matter. The company shows a long cash conversion cycle at 189.38 days, so guidance there could shift sentiment quickly.

Financial snapshot and valuation: current metrics for 569.SI stock

At S$0.09, Vicplas has a market cap of S$45,996,903.00 and shares outstanding 511,076,699. Price-book stands at 0.64 and price-sales at 0.38. The firm reports negative net income per share of -0.00 and no reported EPS, so standard PE is not meaningful.

Key ratios show mixed health. Current ratio is 1.46 and debt-to-equity is 0.58. Operating margin is 22.38% but net margin is slightly negative at -1.95%, reflecting non-operating items and periodic costs.

Operations and sector context: 569.SI stock within Healthcare devices

Vicplas operates in Medical – Devices and pipes. The Healthcare sector in Singapore has outperformed with a one-year gain near 26.74%, supporting interest in small-cap device suppliers. Vicplas relies on contract manufacturing and niche piping contracts, so order book diversity matters.

Operational risks include long receivable days at 137.78 and inventory days at 124.17. These extend the working capital cycle and pressure free cash flow, which sits negative at -0.01 per share.

Technical and market indicators for 569.SI stock

Technically, the stock sits near its 200-day average of S$0.09 and 50-day average of S$0.09. RSI reads 41.00, suggesting no immediate overbought signal. Average volume is 49,996 versus a recent volume of 15,400, showing thin trading.

Price action has been muted year-to-date with a YTD change of -1.10%. Traders should expect higher volatility around the earnings date given low liquidity and small market cap.

Meyka AI grade and model view for 569.SI stock

Meyka AI rates 569.SI with a score out of 100: 61.57 (B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score balances solid operating margins with weak free cash flow and long receivable days.

Meyka AI’s forecast model projects yearly price S$0.09, roughly in line with the current S$0.09. Forecasts are model-based projections and not guarantees.

Final Thoughts

Key takeaways on 569.SI stock center on the earnings print on 12 Mar 2026 and cash flow disclosure. At the current price of S$0.09, the company shows a low price-book of 0.64 but weak free cash flow per share of -0.01. Our practical price targets: bear S$0.05 (-44.44%), base S$0.10 (+11.11%), and bull S$0.14 (+55.56%). Meyka AI’s yearly projection is S$0.09, implying a model-based change of -3.45% versus today. These figures reflect modest upside in a recovery scenario and significant downside if working capital stress persists. Use the earnings release to check order backlog, receivables, and any one-off items. For more background, read company filings at the Vicplas website and market comparisons on Investing.com. This analysis uses Meyka AI-powered market analysis platform outputs and is informational only. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.